Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

Cancer. 2007 Dec 1;110(11):2593-4; author reply 2594. doi: 10.1002/cncr.23063.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / mortality*
  • Clinical Trials, Phase III as Topic
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality*
  • Survival Analysis*
  • Survival Rate / trends*

Substances

  • Antineoplastic Agents